Literature DB >> 7037151

Concepts in causality: chemically induced human urinary bladder cancer.

G M Lower.   

Abstract

A significant portion of the incidence of human urinary bladder cancer can be attributed to occupational and cultural (tobacco smoking) situations associated with exposures to various arylamines, many of which represent established human carcinogens. A brief historical overview of research in bladder cancer causality indicates that the identification of causal agents and causal mechanism has been approached and rests upon information gathered at the organismal (geographical/historical), cellular, and molecular levels of biologic organization. This viewpoint speaks of a natural evolution within the biomedical sciences; a natural evolution from descriptive approaches to mechanistic approaches; and a natural evolution from more or less independent discipline-oriented approaches to hierarchically organized multidisciplinary approaches. Available information relevant to bladder cancer causality can be readily integrated into general conceptual frameworks to yield a hierarchial view of the natural history of urinary bladder cancer, a view consistent with contemporary natural systems and information theory and perhaps relevant also to other chemically induced epithelial cancers. Such frameworks are useful in appreciating the spatial and temporal boundaries and interrelationships in causality and the conceptual interrelationships within the biomedical sciences. Recent approaches in molecular epidemiology and the assessment of relative individual susceptibility to bladder cancer indicate that such frameworks are useful in forming hypotheses.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7037151     DOI: 10.1002/1097-0142(19820301)49:5<1056::aid-cncr2820490535>3.0.co;2-i

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  13 in total

1.  Combretastatin A-4 inhibits cell growth and metastasis in bladder cancer cells and retards tumour growth in a murine orthotopic bladder tumour model.

Authors:  Cheng-Huang Shen; Jia-Jen Shee; Jin-Yi Wu; Yi-Wen Lin; Jiann-Der Wu; Yi-Wen Liu
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

Review 2.  Tumors of the kidney, ureter, and bladder.

Authors:  W A See; R D Williams
Journal:  West J Med       Date:  1992-05

3.  Acetylator polymorphism in Parkinson's disease.

Authors:  J M Ladero; F J Jimenez; J Benitez; M J Fernandez-Gundin; C Martinez; A Llerena; J Cobaleda; J J Muñoz
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

4.  Urinary cytology in workmen engaged in the petrochemical industry with reference to non-industrial risk factors.

Authors:  H D Adolphs; G Hildenbrand; H W Schwabe; E W Vahlensieck
Journal:  Urol Res       Date:  1985

5.  Genetically determined N-acetylation and oxidation capacities in Japanese patients with non-occupational urinary bladder cancer.

Authors:  Y Horai; K Fujita; T Ishizaki
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

6.  Effects of carmustine and lomustine on arylamine N-acetyltransferase activity and 2-aminofluorene-DNA adducts in rat glial tumor cells.

Authors:  C F Hung
Journal:  Neurochem Res       Date:  2000-06       Impact factor: 3.996

7.  Superficial bladder cancer: an update on etiology, molecular development, classification, and natural history.

Authors:  Erik Pasin; David Y Josephson; Anirban P Mitra; Richard J Cote; John P Stein
Journal:  Rev Urol       Date:  2008

8.  Morphological changes of urothelial and intestinal mucosa after ureterosigmoidostomy during experimental urogenic carcinogenesis.

Authors:  F J Deutz; H Rübben; W Küpper; F Hofstädter
Journal:  Urol Res       Date:  1989

9.  Mutagenicity of 4,4'-methylene-bis-(2-chloroaniline) "MOCA" and its N-acetyl derivatives in S. typhimurium.

Authors:  A Hesbert; M C Bottin; J De Ceaurriz
Journal:  Int Arch Occup Environ Health       Date:  1985       Impact factor: 3.015

10.  Anti-Cancer Effects and Tumor Marker Role of Glutathione S-Transferase Mu 5 in Human Bladder Cancer.

Authors:  Yeong-Chin Jou; Shou-Chieh Wang; Yuan-Chang Dia; Shou-Tsung Wang; Min-Hua Yu; Hsin-Yi Yang; Lei-Chin Chen; Cheng-Huang Shen; Yi-Wen Liu
Journal:  Int J Mol Sci       Date:  2021-03-17       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.